Outcomes of a randomised controlled trial of a digital intervention targeting eating disorder symptoms in cisgender sexual minority men

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Objective: There is an unmet need for evidence-based and widely accessible interventions designed to treat eating disorders in sexual minority men, given their heightened vulnerability to developing disordered eating. Digital interventions are a promising avenue for eating disorder treatment because of their accessibility and flexibility in delivery. Here, we present a randomised controlled trial of SEED, a 10-week treatment-focussed digital intervention for eating disorders among sexual minority men. Method: Participants (N = 132 sexual minority men) with a sub-clinical or clinical eating disorder were allocated to one of three conditions: (1) a waitlist control (2) a personalised intervention, where participants received personalised content recommendations based on their individual symptom profile, or (3) a default intervention, in which participants received no personalised recommendations. Changes from baseline in eating disorder symptoms were evaluated via clinical interview and self-report at 10-weeks and 6-months post-intervention. Results: Relative to the waitlist control, participants in the personalised intervention condition reported significantly greater decreases in their global, shape concern, and restraint Eating Disorder Examination interview scores at post-intervention (medium-to-large effects). While we did not observe any significant changes in self-reported eating disorder symptoms, our results are tentative as we were underpowered to detect small-to-medium treatment effects at post-intervention, and at 6-month follow-up. Discussion: Our results highlight SEED as a promising digital intervention for treating eating disorders in sexual minority men. Future studies should further explore the utility of digital treatment-based interventions like SEED through well-powered clinical trials.

Article activity feed